Related Experiment Videos
[Lithium augmentation for mianserin-resistant depression in the elderly]
1Dept. of Psychiatry, Hadassah-University Hospital, Ein Karem, Jerusalem.
Harefuah
|October 1, 1992
Summary
This study explores treating elderly depression resistant to standard treatments. Combining mianserin and lithium proved safe and effective for a 73-year-old patient, offering new hope for geriatric depression management.
Area of Science:
- Geriatric Psychiatry
- Pharmacology
Background:
- Elderly depression often presents as prolonged and treatment-resistant.
- Older adults are more susceptible to anticholinergic and cardiac side effects of tricyclic antidepressants (TCAs).
- Newer antidepressants like trazodone and mianserin have fewer side effects but similar efficacy to TCAs, leaving many elderly patients with resistant depression.
Observation:
- Limited data exists on potentiating trazodone or mianserin with lithium, especially in elderly patients.
- Previous studies show mixed results for lithium combination therapy with trazodone and mianserin in adults.
- A 73-year-old male patient with resistant depression, contraindicated for TCAs, was treated.
Findings:
- The combination of mianserin and lithium was found to be safe and effective in treating the elderly patient's resistant depression.
- This case contrasts with some previous findings suggesting lower efficacy for lithium and trazodone combinations.
Implications:
- Mianserin and lithium combination therapy presents a viable and safe option for managing treatment-resistant depression in elderly patients.
- This approach may be particularly beneficial for older adults with contraindications to traditional antidepressant medications.
- Further research is warranted to explore the efficacy and safety of this combination in a larger geriatric population.